Quick Answer
CYTOKINETICS INC reported Long Term Debt of $246.38 million for the year ending 2025.
- CYTOKINETICS INC showed an increase of +164.3% in Long Term Debt from 2024 to 2025.
- This data is from CYTOKINETICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2016: $29.47 million | Q2 2016: $29.60 million | Q3 2016: $29.74 million | Q1 2017: $25.20 million | Q2 2017: $22.84 million | Q3 2017: $20.47 million | Q1 2018: $31.95 million | Q2 2018: $30.66 million | Q3 2018: $38.13 million | Q1 2019: $36.38 million | Q2 2019: $44.47 million | Q3 2019: $44.76 million | Q1 2020: $45.34 million | Q2 2020: $45.63 million | Q3 2020: $45.92 million | Q1 2021: $40.87 million | Q2 2021: $35.54 million | Q3 2021: $30.20 million | Q1 2022: $61.17 million | Q2 2022: $62.34 million | Q3 2022: $63.54 million | Q1 2023: $64.11 million | Q2 2023: $62.49 million | Q3 2023: $60.89 million | Q1 2024: $56.82 million | Q2 2024: $92.83 million | Q3 2024: $93.02 million | Q1 2025: $92.03 million | Q2 2025: $159.06 million | Q3 2025: $158.75 million.
- Historical annual values: Fiscal year 2025: $246.38 million | Fiscal year 2024: $93.23 million | Fiscal year 2023: $58.38 million | Fiscal year 2022: $63.81 million | Fiscal year 2021: $47.37 million | Fiscal year 2020: $46.21 million | Fiscal year 2019: $45.05 million | Fiscal year 2018: $39.81 million | Fiscal year 2017: $31.78 million | Fiscal year 2016: $27.38 million | Fiscal year 2015: $14.64 million | Fiscal year 2014: $0.00.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: